The workshop will focus on four key discussion points:
Head of Marketing and Sales Natasha Robshaw explains why the consultation has been organised, and what BioMed Central hope to gain from the day;
"In this new environment of Open Access publishing our business model is still evolving. At BioMed Central we believe we need the advice and involvement of the community to help us with important issues such as payment models to ensure the continued success of Open Access publishing. We hope that this consultation will allow us to explore how to channel funds to pay for Open Access publishing in the future – in a way that truly fits the needs of the community."
Sixteen invited representatives of the library and funding communities have accepted BioMed Central's invitation to the one-day meeting. They include:
Michael Leach, Harvard University, USA
Nicole Pinhas, INSERM, France
Stéphanie Lux, INSERM, France
Antonio Fantoni, La Sapienza , Italy
Ann Okerson, Yale University, USA
Norbert Lossau, Bielefeld University, Germany
Mary Ryan, University of Arkansas for Medical Sciences, USA
Fytton Rowland, Loughborough University, UK
Ingegerd Rabow, Lund University, Sweden
Linda Watson, University of Virginia, USA
Peter Morgan, Cambridge University, UK
Robert Terry, Wellcome Trust, UK
Heather Weaver, Council for the Central Laboratory of the Research Councils (CCLRC), UK
Stephane Goldstein, Research Councils United Kingdom
Joan Leishmanm, University of Toronto, Canada
Press Office Contacts:
Grace Baynes for BioMed Central
Telephone: 44-207-323-9988
E-mail: press@biomedcentral.com
About BioMed Central
BioMed Central (http://www.biomedcentral.com) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science. In addition to open-access original research, BioMed Central also publishes reviews and other subscription-based content.
BioMed Central's business model is based on charging authors to publish, and then making the content free to readers. Under membership agreements, authors from member institutions will not be asked to pay an article processing charge when publishing research. The charge is instead covered by the institution's BioMed Central membership. This applies to all of BioMed Central's journals 100+ peer-reviewed journals. Upon acceptance, the article becomes available online without charge to readers worldwide.
BioMed Central's Institutional Membership Program was launched in January 2002 and now has well over 400 members, including some of the world's most prestigious academic institutions.